Granules India Q4 Net Profit Jumps 33% YoY to ₹202 Cr; Revenue Surges 23%

Synopsis: Granules India Ltd delivered a strong Q4 FY26 performance, reporting robust growth in both revenue and profitability driven by improved operational efficiency and margin expansion. The company continues to benefit from strong demand across key segments, reflecting consistent earnings momentum. 

Granules India Ltd is a vertically integrated pharmaceutical company engaged in manufacturing active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosage formulations. The company has built a strong presence in global markets, particularly in North America and Europe, with a focus on cost efficiency and large-scale manufacturing. 

As of today, Granules India Ltd is trading at Rs. 705, with a market capitalization of Rs. 17,461 crore. The stock has recorded a 52-week high of Rs. 731 and a low of Rs. 431, indicating a strong upward movement over the period. The company maintains healthy return ratios with ROCE of 15.5% and ROE of 13.7%, supported by improving operational performance. Additionally, it offers a dividend yield of 0.21%, adding to shareholder returns. 

In Q3 FY26 (December 2025), the company reported revenue of Rs. 1,384 crore, reflecting steady growth driven by strong demand across segments. The net profit stood at Rs. 150 crore, while operating profit was Rs. 308 crore, indicating stable margins and consistent operational performance during the quarter. 

In Q4 FY26 (March 2026), Granules India reported revenue of Rs. 1,479 crore, marking a 6.9% QoQ growth compared to Rs. 1,384 crore in Q3 and a 23.3% YoY growth compared to Rs. 1,199 crore in Q4 FY25. On the profitability front, the company reported net profit of Rs. 202 crore, reflecting a 34% QoQ growth compared to Rs. 150 crore in Q3 and a 32.6% YoY growth. The operating profit increased to Rs. 352 crore, compared to Rs. 308 crore in Q3, indicating strong operating leverage. 

Granules India Ltd has delivered a strong Q4 performance, driven by robust revenue growth, margin expansion, and improved operational efficiency. The company’s focus on scale, cost optimization, and strong global demand positions it well for sustained growth. With improving profitability and a stronger balance sheet, Granules India appears well-placed to maintain its earnings momentum in the coming quarters.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing. 

The post Granules India Q4 Net Profit Jumps 33% YoY to ₹202 Cr; Revenue Surges 23% appeared first on Trade Brains.